JPRN-UMIN000003694已完成未知
Effect of Vitamine D3 for the patients whith chronic hepatitis C who recieved PEG-interferon alpha plus ribavirin: possible applicaition for database establishment. - EVIDENCE study
Division of Gastroenterology, Tohoku Univerisity Graduate School of Medicine0 个研究点目标入组 10 人开始时间: 2010年6月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
1(OH) vitamin D3 could improve the sensitivity of Peg-IFN/RBV therapy on HCV-infected hepatocytes by reducing the IP-10 production from PBMCs and ISGs expression in the liver.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Any contraindication for (PEG) interferon, ribavirin, and Vitamine D3 suppliments.
研究者
相似试验
Unknown
不适用
Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?Hepatitis CNCT01146626Ziv Hospital60
Unknown
不适用
Vitamin D Treatment in Patients With Chronic Hepatitis CChronic Hepatitis CNCT00804752Hillel Yaffe Medical Center
Unknown
不适用
Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?Chronic Hepatitis CNCT01151397Ziv Hospital60
终止
3 期
Long Term Vitamin D Therapy in HCV Treated PatientsChronic Hepatitis CNCT01997203Dr. Nadia AbdelAaty AbdelKader100
Unknown
4 期
Investigating the Effects of Hydroxyvitamin D3 on Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingAdult ALLVitamin D3 DeficiencyNCT05340985Tehran University of Medical Sciences54